Literature DB >> 6851553

Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.

F B O'Brien, W C Stewart, F M Sturtevant.   

Abstract

Pelvic inflammatory disease (PID) was recorded for 365 of 10,760 women using the Cu-7 for up to 48 months during clinical investigations in the United States. This involved a total exposure of 242,169 woman-months, or some 20,000 woman-years. The overall incidence of PID was 18 cases/1000 woman-years. Incidence was inversely related to age and to duration of use. It was statistically significantly greater in parous subjects than in nulliparous, after stratifying for age. The estimated rates in this study do not differ markedly from those in most other prospective investigations.

Entities:  

Keywords:  Acceptor Characteristics; Acceptors; Adnexitis; Age Factors; Americas; Clinical Research; Contraception; Contraceptive Methods; Demographic Factors; Developed Countries; Diseases; Family Planning; Family Planning Programs; Fertility; Fertility Measurements; Incidence; Infections; Iud; Iud, Copper Releasing; Measurement; North America; Northern America; Parity; Pelvic Inflammatory Disease; Population; Population Characteristics; Population Dynamics; Reproductive Tract Infections; Research Methodology; United States

Mesh:

Year:  1983        PMID: 6851553     DOI: 10.1016/0010-7824(83)90082-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

1.  Incidence of pelvic inflammatory disease.

Authors:  F M Sturtevant
Journal:  Br J Gen Pract       Date:  1990-02       Impact factor: 5.386

2.  Sexually transmitted diseases and Chlamydia trachomatis in women consulting for contraception.

Authors:  D Avonts; M Sercu; P Heyerick; I Vandermeeren; P Piot
Journal:  J R Coll Gen Pract       Date:  1989-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.